Thought Leadership
Interview on the FDA Pipeline
June 2021
Pharmacy Times

Axinn partner Chad Landmon participated in a two-part video interview with Pharmacy Times. They discussed key events in the FDA pipeline, such as Emergency Use Authorizations during COVID-19 and the future of narrowed approvals. Click below to access the interviews.

Part 1: "Key Events in the FDA Pipeline During COVID-19"
Part 2: "The Future of Pharmaceuticals and the FDA Pipeline"

By using the Axinn, Veltrop & Harkrider LLP website with cookies enabled on your browser, you agree to our use of cookies during your browsing experience. Learn more about our privacy policy.